Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 159

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 159
---
 any pending legal proceedings.

<div align='center'>96

MANAGEMENT</div>

Executive Officers, Directors and Key Personnel

The following table sets forth information regarding our executive
officers and directors:

| Name              |     | Age |     | Position                                        |
| Amir Avraham      |     |  49 |     | Interim Chief Executive Officer                 |
| Inna Martin       |     |  49 |     | President, Chief Operating Officer and Director |
| Arie Gordashnikov |     |  41 |     | Chief Financial Officer and Treasurer           |
| Daniel Bartal     |     |  59 |     | Chairman, Director                              |
| Matti Munk        |     |  53 |     | Director                                        |
| Yoram Drucker     |     |  59 |     | Director                                        |

Amir Avraham, 49,was appointed Chief
Executive Officer on an interim basis, on May 22, 2205 following Mr. Akunis resignation from such position. Since April 2024, Mr.
Avraham has been a financial consultant with the Company, on a part time basis. Prior to his appointment as interim Chief Executive at
the Company, since February 2017 he has been General Manager and Chief Financial Officer at OCON Therapeutics, a global biotech company
drug device company, operating in Israel and Switzerland, where he led strategic planning and capital raises totaling over $15 million
while managing legal, financial, and global activities. Prior thereto, he was from January 2013 to February 2017 he was Chief Financial
Officer at Secure Islands Technologies, a cybersecurity firm acquired by Microsoft, where he led financial operations across the US,
UK, and Switzerland, managed investor relations, and was instrumental in both a $20 million fundraising round and the Microsoft acquisition
process. From February 2008 to January 2013, he was Chief Financial Officer at Van Leer Technology Ventures, a venture company, where
he oversaw all financial reporting. Prior thereto from 2004 to 2008, he was associated with the Israel office of Deloitte, where he led
and participated in numerous financial audits for organization of various sizes.

Mr. Avraham is a licensed CPA and holds an
MBA in Finance from the Hebrew University of Jerusalem.

Inna Martin, 49, has joined the Company
as Chief Executive Officer, President and director in November 2019 and served as Chief Executive Officer through December